Discover
AMRN
Amarin Corporation plc
16.47
1 x 13.94
1 x 18.88
bid
ask
+
0.53
3.32%
1 @ 04:00 PM
16.47 +0.00 (0.00%)
| Ytd | 17.98% | |
| 1y | -2.02% |
15.81
day range
16.56
12.96
52 week range
20.90
| Open | 15.89 | Prev Close | 15.94 | Low | 15.81 | High | 16.56 | Mkt Cap | 345.36M |
| Vol | 72.32K | Avg Vol | 78.25K | EPS | -1.60 | P/E | N/A | Forward P/E | -2.17 |
| Beta | 1.93 | Short Ratio | 12.75 | Inst. Own | 17.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 14.82 | 200-d Avg | 15.43 | 1yr Est | 1.00 |
AMRN News
benzinga.com
Amarin Highlights Recent FDA Approval Of Injectable Apolipoprotein C-III Therapies For Treatment Of
Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular
globenewswire.com
Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving
Clinically Validated, Increasingly Prescribed, Widely Reimbursed, and Affordable, VASCEPA Expected t
benzinga.com
U.S. Supreme Court Rules In Favor Of Hikma Pharmaceuticals V Amarin Pharmaceuticals Over Patent Infr
https://www.supremecourt.gov/opinions/25pdf/24-889_5i36.pdf